Biotech

Catch-all for biotech content not captured by a more specific sub-Sector. Editors must pick a sub-Sector first; only use this term when no sub-Sector applies.
AI & ML
Biotech
Datatech

GuideAI and vRad renew data deal to extend AI vascular diagnostics

GuideAI secures exclusive imaging data from 2,100 US hospitals to train AI models across multiple vascular diseases.
GuideAI secures exclusive imaging data from 2,100 US hospitals to train AI models across multiple vascular diseases.
Biotech

Seer CFO departure signals routine leadership change at proteomics firm

David Horn exits Seer after six years as CFO, replaced internally by VP of Financial Planning Charles Endweiss from October.
David Horn exits Seer after six years as CFO, replaced internally by VP of Financial Planning Charles Endweiss from October.
Biotech
Sustainability
AI & ML

Ingenza launches UNVAIL to find novel proteins via AI-driven search

Edinburgh CRDMO Ingenza deploys AI-ML protein discovery to serve pharma, chemicals and sustainable fuels simultaneously.
Edinburgh CRDMO Ingenza deploys AI-ML protein discovery to serve pharma, chemicals and sustainable fuels simultaneously.
AI & ML
Space
Biotech
Datatech

LEAP 2026 opens as Saudi Arabia bets diversification on AI

The fifth edition opened in Malham today with 1,289 registered investors representing $14.5tn in assets, though the opening-day deal total has yet to land.
The fifth edition opened in Malham today with 1,289 registered investors representing $14.5tn in assets, though the opening-day deal total has yet to land.
Biotech
AI & ML

Novo Nordisk and AWS unite to compress drug discovery timelines

A London co-innovation hub and cloud-first deal positions agentic AI at the heart of pharma's race to shorten the path from target
A London co-innovation hub and cloud-first deal positions agentic AI at the heart of pharma's race to shorten the path from target
Fintech
Biotech

NatWest Venture Banking hires life sciences lead from HSBC

Emily Pilkington joins from HSBC Innovation Banking to head NatWest's life sciences and healthcare venture unit.
Emily Pilkington joins from HSBC Innovation Banking to head NatWest's life sciences and healthcare venture unit.
Media & Publishing
AI & ML
Biotech

RWS acquires Acolad to extend AI language platforms across Europe

The AIM-listed AI solutions group absorbs a 1,200-person European language services firm, betting that enterprise AI still needs human cultural fluency.
The AIM-listed AI solutions group absorbs a 1,200-person European language services firm, betting that enterprise AI still needs human cultural fluency.
Sustainability
Biotech

BASF files novel PPO herbicide to tackle resistant grass weeds

Replexor Active targets a gap in weed control that has narrowed farmers' options as herbicide resistance spreads globally.
Replexor Active targets a gap in weed control that has narrowed farmers' options as herbicide resistance spreads globally.
Biotech
Wellbeing

Ocugen licenses gene therapy for blindness to MENA via Roots Pharma

A $255m milestone deal routes a US gene therapy for inherited blindness into the Middle East, where consanguinity-linked RP rates are among the world
A $255m milestone deal routes a US gene therapy for inherited blindness into the Middle East, where consanguinity-linked RP rates are among the world
Biotech

LiqTech wins China vessel order as marine emissions rules tighten

Silicon carbide filtration crosses into EGR vessel platforms, signalling broader regulatory pressure reshaping commercial shipping globally.
Silicon carbide filtration crosses into EGR vessel platforms, signalling broader regulatory pressure reshaping commercial shipping globally.
Biotech

Consolidated Water wins 25-year Cayman licence amid tourism surge

A new 25-year exclusive water licence for Grand Cayman locks in regulated infrastructure as record tourism reshapes island utility economics.
A new 25-year exclusive water licence for Grand Cayman locks in regulated infrastructure as record tourism reshapes island utility economics.
Biotech

Galectin Therapeutics aligns with FDA on belapectin Phase 3 design

Galectin said a Type C meeting produced agreement on the primary endpoint and regulatory path for a full approval trial in MASH cirrhosis.
Galectin said a Type C meeting produced agreement on the primary endpoint and regulatory path for a full approval trial in MASH cirrhosis.
Biotech

CCEC and CMA CGM form JV to build $82.8m LNG bunkering vessel

An Athens-Paris joint venture brings TotalEnergies into a 12-year LNG bunkering charter, embedding fossil-transition infrastructure into global shipping.
An Athens-Paris joint venture brings TotalEnergies into a 12-year LNG bunkering charter, embedding fossil-transition infrastructure into global shipping.
Biotech

Cespira and Volvo Group back hydrogen ICE for long-haul trucks

Cespira's HPDI fuel system will power Volvo's 13-litre engine on hydrogen, targeting European commercial launch before 2030.
Cespira's HPDI fuel system will power Volvo's 13-litre engine on hydrogen, targeting European commercial launch before 2030.
Biotech

PureCycle and IPL Schoeller prove recycled plastic at commercial scale

A US recycler, a global packaging firm and a fermented-food brand together hit the first commercial food-contact milestone for dissolution-recycled polypropylene.
A US recycler, a global packaging firm and a fermented-food brand together hit the first commercial food-contact milestone for dissolution-recycled polypropylene.
Biotech

Kraken Robotics clears regulatory hurdle for Covelya Group acquisition

The Canadian subsea robotics firm is set to close a deal that consolidates six underwater-tech specialists into a single global platform.
The Canadian subsea robotics firm is set to close a deal that consolidates six underwater-tech specialists into a single global platform.
Biotech

Dragonfly Energy wins US patent for solid-state battery process

A US patent allowance for powderised solid-state electrolytes edges Dragonfly Energy closer to nonflammable battery commercialisation.
A US patent allowance for powderised solid-state electrolytes edges Dragonfly Energy closer to nonflammable battery commercialisation.
Biotech

ProLogium and Elysian target 420 Wh/kg cells for electric aviation

A Taiwan battery maker and a Dutch aerospace startup are testing next-generation cells that could make 1,000 km zero-emission flights viable.
A Taiwan battery maker and a Dutch aerospace startup are testing next-generation cells that could make 1,000 km zero-emission flights viable.
Biotech

Dragonfly Energy wins European patent for solvent-free battery tech

A European patent allowance for dry electrode manufacturing bolsters Dragonfly Energy's IP position in next-generation solid-state battery commercialisation.
A European patent allowance for dry electrode manufacturing bolsters Dragonfly Energy's IP position in next-generation solid-state battery commercialisation.
Biotech

Beam Global wins EU patent for passive battery thermal tech

A European patent for Beam Global's phase-change battery composite strengthens its IP position across defence, robotics and EV markets.
A European patent for Beam Global's phase-change battery composite strengthens its IP position across defence, robotics and EV markets.
Subscribe to Biotech